The findings, published Friday in JAMA Health Forum, suggest that blockbuster medications such as Novo Nordisk A/S’s Ozempic ...
For the first time in a decade, obesity in the U.S. is declining — and a new study suggests it’s because of wildly popular medications such as Ozempic.